Related Experiment Video
Updated: Jan 28, 2026

Using Sniper-Cas9 to Minimize Off-target Effects of CRISPR-Cas9 Without the Loss of On-target Activity Via Directed Evolution
Published on: February 26, 2019
CRISPR/Cas9: a powerful tool for identification of new targets for cancer treatment
Bin Liu1, Ali Saber1, Hidde J Haisma1
1Department of Chemical and Pharmaceutical Biology, Groningen Research Institute of Pharmacy, University of Groningen, The Netherlands.
Abstract:
Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR associated nuclease 9 (Cas9), as a powerful genome-editing tool, has revolutionized genetic engineering. It is widely used to investigate the molecular basis of different cancer types. In this review, we present an overview of recent studies in which CRISPR/Cas9 has been used for the identification of potential molecular targets. Based on the collected data, we suggest here that CRISPR/Cas9 is an effective system to distinguish between mutant and wild-type alleles in cancer. We show that several new potential therapeutic targets, such as CD38, CXCR2, MASTL, and RBX2, as well as several noncoding (nc)RNAs have been identified using CRISPR/Cas9 technology. We also discuss the obstacles and challenges that we face for using CRISPR/Cas9 as a therapeutic.
Insights
The CRISPR/Cas9 genome-editing tool revolutionizes cancer research by identifying novel therapeutic targets. This technology effectively distinguishes between mutant and wild-type alleles, paving the way for new cancer treatments.
Area of Science:
- Biotechnology
- Genetics
- Oncology
Background:
- The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR associated nuclease 9 (Cas9) system is a revolutionary genome-editing tool.
- CRISPR/Cas9 is extensively utilized to explore the molecular underpinnings of various cancer types.
Purpose of the Study:
- To review recent advancements in CRISPR/Cas9 applications for identifying potential molecular targets in cancer.
- To highlight the efficacy of CRISPR/Cas9 in differentiating between mutant and wild-type alleles in cancer contexts.
Main Methods:
- Literature review of studies employing CRISPR/Cas9 technology in cancer research.
- Analysis of identified therapeutic targets and noncoding RNAs (ncRNAs) discovered through CRISPR/Cas9 applications.
Main Results:
- CRISPR/Cas9 has successfully identified several promising therapeutic targets, including CD38, CXCR2, MASTL, and RBX2.
- The technology has also led to the discovery of novel noncoding RNAs (ncRNAs) with potential roles in cancer.
- CRISPR/Cas9 demonstrates effectiveness in distinguishing between mutant and wild-type alleles, crucial for targeted therapies.
Conclusions:
- CRISPR/Cas9 is a powerful tool for advancing cancer research and identifying therapeutic targets.
- The technology holds significant promise for developing novel cancer treatments by enabling precise genetic manipulation and target identification.
- Challenges and obstacles related to the therapeutic application of CRISPR/Cas9 warrant further investigation.
More Related Videos
Related Concept Videos
CRISPR
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
CRISPR/Cas9 Genome Editing
Treatment Resistant Cancers
Targeted Cancer Therapies
There are several types of targeted therapies against...
Power

